Security · CUSIP 45790W108
INOZYME PHARMA INC
COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 87
Added / reduced
0 / 0
net -50.6M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2025
Nothing to show.
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Beryl Capital Management LLC | Sold out | -6,321,584 | -100.0% |
| Pivotal bioVenture Partners Investment Advisor LLC | Sold out | -4,494,851 | -100.0% |
| GLAZER CAPITAL, LLC | Sold out | -4,330,220 | -100.0% |
| Sofinnova Investments, Inc. | Sold out | -4,280,308 | -100.0% |
| ODDO BHF ASSET MANAGEMENT SAS | Sold out | -3,200,000 | -100.0% |
| Trium Capital LLP | Sold out | -3,173,454 | -100.0% |
| BlackRock, Inc. | Sold out | -2,663,678 | -100.0% |
| VANGUARD GROUP INC | Sold out | -2,498,649 | -100.0% |
| NEA Management Company, LLC | Sold out | -2,437,689 | -100.0% |
| ALPINE ASSOCIATES MANAGEMENT INC. | Sold out | -2,188,100 | -100.0% |
77 more rows. Subscribe for $29/month to see every row, download the data and use the API.